Treatment outcome in tuberculosis patients under DOTS treatment, tuberculosis unit, Nahan, Himachal Pradesh, 2013-2015: a record based descriptive study

Rashmi Kashyap, Kamaljit Singh


Background: Tuberculosis (TB) has existed for millennia and remains a major global health problem. There has been significant progress in cure rates achieved in revised national tuberculosis programme (RNTCP), however concerns regarding effectiveness of RNTCP regimens, still exist. These concerns could be addressed through an assessment of treatment outcome. The present study was conducted to ascertain the treatment outcome in tuberculosis patients under DOTS treatment.

Methods: A record based descriptive study was conducted in patients enrolled under directly observed treatment strategy (DOTS). The data included the summary of case findings as new smear positive, new smear negative, new extrapulmonary, new others, relapse, failure, treatment after default, category II. Treatment outcome was assessed as cured, treatment completed, died, loss to follow up, failure and transferred out. Different variables were represented as frequency distribution and percentages. Chi square test was used to observe the association of different variables with the outcome of the disease.

Results: A total of 899 patients were enrolled under DOTs treatment for tuberculosis. Sputum positivity was present in 481 (72.8%) patients. Outcome showed 384 (79.8%) patients as cured, treatment completed in 414 (81.8%) patients and treatment success rate of 798 (89.7%). Treatment failure was observed 9 (1.9%) patients.

Conclusions: Treatment success rate of TB patients in this study was encouraging for TB control through DOTS strategy. However, to reduce poor treatment outcome, patients should be strictly followed by health workers or ASHAs. 


Pulmonary tuberculosis, Cure rate, Treatment success

Full Text:



TB India 2016 Revised National TB Control Programme Annual Status Report”, New Delhi, 2016

Global Tuberculosis Control 2015, WHO, Geneva, 2015 - Available at:

Basic Statistics: About Incidence, Prevalence, Morbidity, and Mortality – Statistics Teaching Tools, Department of Health, New York State - Available at: Accessed on 3 March 2018.

WHO: Global Tuberculosis Report 2016. Available at: report/en/. Accessed on 9 May 2017

World Health Organization (2006) The Stop TB Strategy: Building on and enhancing DOTS to meet the TB-related Millennium Development Goals (MDGs). Geneva, Switzerland.

World Health Organization (2010). The global plan to stop TB, 2011-2015/Stop TB Partnership: Transforming the fight towards elimination of tuberculosis. Geneva, Switzerland.

New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare Nirman Bhavan; 2010. Government of India. Managing the Revised National Tuberculosis Control Programme in your area. A Training Course-modules (1-4)-Central TB Division; 2010: 1.

New Delhi: Central TB division, Ministry family of health and family welfare, Nirmal Bhawan; 2009. Mar, TB India 2009, RNTCP status report; 2009: 1–5.

RNTCP- Government of India TB Treatment & Care. Available at: Accessed on 9th May 2017.

Directorate of Health. Hyderabad, India: 2006. State TB Control Society, RNTCP Status Report; Annual Report 2006. Available at: /documents.asp#. Directorate of Health Services, Department of Health and Family Welfare. Himachal Pradesh, India: Health at a glance; 2005. Accessed on 04 August, 2010.

Park K. Epidemiology of communicable diseases. Park’s textbook of preventive and social medicine. 23rd edition. Jabalpur: Banarsidas Bhanot publishers; 2013: 176-200.

Uplekar MW. Attention to gender issues in tuberculosis to control. Int J Tuberc Lung Dis. 2001: 220-224.

Sharma A, Kansal D, Katoch K, Sharma PK, Bansal R, Sharma T. Treatment outcome of new smear positive patients of pulmonary tuberculosis treated under directly observed treatment, Short course in a rural tertiary care hospital of a hilly area. Int J Community Med Public Health. 2016:3:2129-32.

Sophia V, Balasangameshwara VH, Jaganatha PS, Kumar P. Initial drug resistance among tuberculosis patients under DOTS programme in Bangalore city. Ind J Tub. 2004;51:17-21.

Sharma SK, Kaushik G, Jha B, George N, Arora SK, Gupta D, et al. Prevalence of multidrug tuberculosis among newly diagnosed cases of sputum positive pulmonary tuberculosis. Indian J Med Res. 2011;133:308-11.

Mahadev P, Kumar P, Agarwal SP, Chauhan LS, Srikantaramu N, et al. Surveillance of drug resistance to anti tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj in Orissa. Indian J Tuberc. 2005;52:5-10.

Sharma A, Kansal D, Sharma PK, Bansal R, Sharma T. Socio-demographic profile of NSP patients of PTB in tertiary care hospital. India bn J Pharmacy Pharmacol. 2016:3(4);162-4.

Tahir M, Sharma SK, Rohrberg DS, Gupta D, Singh UB, Sinha PK. DOTS at a tertiary care centre in northern India: successes, challenges & next steps in tuberculosis Control. Indian J Med Res. 2006.123;702-6.

Ahmed J, Chadha VK, Singh S, Venkatachalappa B, Kumar P. Utilization of RNTCP services in Rural area of Bellary district Karnataka by gender, age and distance from health centre. Indian J Tuberc. 2009;56:62-8.

Mishra A, Mishra S, Chouksy M, Gautam P, Verma P, Srivastava D, et al. Study of effectiveness of DOTS on tuberculosis patients treated under RNTCP program. NTI Bulletin. 2007;43:47-50.

Gaikwad A, Deopujari K. A study of clinical profile and treatment outcome of DOTS regimen in 250 pulmonary and extrapulmonary tubercular patients in Hamida hospital, Bhopal, 2011. Chest. 2012;142:288-9.

Prakasha SR, Suresh G, D’sa IP, Shetty SS, et al. Mapping the Pattern and trends of Extrapulmonary Tuberculosis. J Glob Infect Dis. 2013;5(2):54–9.

Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extra pulmonary tuberculosis. Clin Infect Dis. 2004;38:199–205.

Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM. Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2002;6:879–86.

Musellim B, Erturan S, Sonmez Duman E, Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: Factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9:1220–3.

Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extra pulmonary tuberculosis: Clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435–41.

Chadha SL, Bhagi RP. Treatment outcome in tuberculosis patients placed under directly observed treatment short course (DOTS): A cohort study. Indian J Tuberc. 2000;47:155–8.

Ramachandrana G, Hemanth Kumar AK, Chandrasekaran V, Kannan T, Vijayalakshmi R, Azger Dusthackeer VN, et al. Factors influencing tuberculosis treatment outcome in adult patients 2 treated with thrice- weekly regimens in India. Antimicrob Agents Chemother. 2017;61(5)pii: e02464-16.

Piparva KG. Treatment outcome of tuberculosis patients on dots therapy for category 1 and 2 at district tuberculosis centre. Int J Pharm Sci Res 2017;8(1):207-12.

Ahmad SR, Velhal GD. Study of treatment outcome of new sputum smears positive TB cases under - strategy. Int J Pharm Bio Sci. 2013;4:1215-22.

Saha TK, Chattopadhyay A, Sain S, Boral K, Yasmin S, Basu R. A Follow-up Study on the Performance, Outcome and present status of patients treated Under ‘RNTCP’ in a slum area of Kolkata J Dental Medical Sci. 2013;6(3):63-7.

Prasad R, Srivastawa SK, Ratan RK, Srivastawa P. Report on Revised National Tuberculosis Control Programme Urban Project in Lucknow. Indian J Tub. 2000;47:159.